The first Biomedical Innovation Summit Forum for the development of biomedicine driven by innovation in 2035 was held in Tianjin

October 18-20, 2019, Academician Yao Xinsheng, academician Chen Kaixian, academician Liu Changxiao, academician Yang Baofeng, Academician Wang Rui and nearly a thousand organization leaders, policy makers and industry experts from biomedical research institutes, universities, enterprises, clinical units, professional institutions and government departments gathered in Tianjin, a beautiful coastal city, and participated in the two-day "innovation driven in 2035 The first Biomedical Innovation Summit Forum with the theme of "development of biomedicine", the participants jointly celebrated the 60th anniversary of the founding of Tianjin Pharmaceutical Research Institute, the 50th anniversary of academician Liu Changxiao's research on pharmacokinetics, and the 50th anniversary of the founding of Chinese herbal medicine magazine This forum is a grand meeting to stimulate innovative ideas of biomedicine and promote academic exchanges and industrial development The forum is sponsored by the medical and Health Department of Chinese Academy of engineering, China Pharmaceutical Association, China Merchants Health Industry Investment Co., Ltd and Tianjin Pharmaceutical Research Institute, and organized by Tianjin Chinese herbal medicine journal, National Key Laboratory of drug release technology and pharmacokinetics, Tianjin Pharmaceutical Research Institute new drug evaluation Co., Ltd and Tianjin Science and Technology Association Academician Liu Changxiao, academician Yao Xinsheng, Academician Wang Rui, chairman of China Pharmaceutical Association sun Xianze, vice chairman of Tianjin CPPCC Qi Chengxi, office director of the medical and Health Department of Chinese Academy of Engineering Zhang Wentao, assistant to the general manager of China Merchants Group and chairman of Tianjin Pharmaceutical Research Institute Li Yadong, President of China Pharmaceutical Industry Research Institute Wei Baokang and some industry competent departments in Tianjin Leaders and experts attended the opening ceremony of the summit forum President Li Yadong delivered a welcome speech: "when you are still immersed in the joy and pride of the 70th anniversary of the founding of the people's Republic of China, we gathered in Tianjin to celebrate the 60th anniversary of the founding of Tianjin Pharmaceutical Research Institute and the 50th anniversary of the founding of Chinese herbal medicine magazine, and the 50th anniversary of academician Liu Changxiao's engagement in pharmacokinetic research, and take this opportunity to hold the first Biomedical Innovation Summit Forum, and conspire together Innovation and development of biomedical industry in China On behalf of Tianjin Pharmaceutical Research Institute, I would like to extend a warm welcome and heartfelt thanks to all of you! " He said that in the past 60 years, people of Tianjin Pharmaceutical Research Institute have always taken "science and technology to promote medicine and benefit human beings" as their mission, worked hard and made unremitting efforts to break through the international blockade, fill in domestic gaps and improve their self-sufficiency They have created many "firsts" in China's pharmaceutical industry, contributed a large number of new and good drugs to the society and made due contributions to the development of China's pharmaceutical industry 。 Academician Liu Changxiao and Journal of Chinese herbal medicine have become important marks of Tianjin Pharmaceutical Research Institute's special contribution to the industry In 2018, Tianjin Pharmaceutical Research Institute, following the pace of mixed ownership reform of state-owned enterprises, joined hands with China Merchants Group and successfully realized the mixed ownership reform As an important platform for China Merchants Group to layout the large health industry, it will strive to become a scientific research institution, high-quality drug manufacturer with excellent pharmaceutical research and development capabilities, with a more open, inclusive, mutually beneficial and win-win philosophy High quality health products and service providers, strive to build into "World Pharmaceutical Research Institute of Centennial Pharmaceutical Research Institute" (Li Yadong, assistant general manager of China Merchants Group and chairman of Tianjin Pharmaceutical Research Institute) Sun Xianze, chairman of the board of directors, said in his speech that in the past 60 years, with the continuous development of the founding of new China, Tianjin Pharmaceutical Research Institute has developed from a scientific research institute to a comprehensive high-tech pharmaceutical enterprise focusing on pharmaceutical research and development, including technical services, pharmaceutical production and sales Tianjin Pharmaceutical Research Institute has always been committed to supporting national industry, and has been doing everything to change the situation of lack of medical care and drugs in China He has made great contributions, and a large number of well-known experts and scholars, represented by academician Liu Changxiao, have emerged Academician Liu is one of the leaders and pioneers of pharmacokinetics in China The established pharmacokinetic laboratory has developed into a well-known pharmacokinetic laboratory at home and abroad, making important contributions to promoting the level of innovative drug research and development in China Chinese herbal medicine is a scientific and technological journal jointly sponsored by Tianjin Pharmaceutical Research Institute and China Pharmaceutical Association It has won many national awards and other honors, and has made positive contributions to the development, standardization and modernization of traditional Chinese medicine In the new historical journey, we hope that Tianjin Pharmaceutical Research Institute will not forget its original mind and mission, continue to improve its ability of independent innovation, emerge more scientific and technological achievements with independent intellectual property rights, continue to give full play to the advantages of state-level industrial research institutes, strengthen the research on common technologies in the industry, pass on from generation to generation, create new brilliance, and build a world-class research institute as soon as possible (sun Xianze, President of China Pharmaceutical Association) Zhang Wentao, director of the office of the medical and Health Department of the Chinese Academy of engineering, said in his speech that in the past 60 years, Tianjin Pharmaceutical Research Institute has maintained its patriotism, remained committed to providing technical support for the pharmaceutical industry and made outstanding contributions to the development of China's pharmaceutical industry The Journal of Chinese herbal medicine, which was founded by him, has developed into a leading academic journal of traditional Chinese medicine Shi is also the academic leader of the medical and Health Department of Chinese Academy of engineering, laying a pioneering technology for pharmacokinetic research in China I believe that Tianjin Pharmaceutical Research Institute will make great progress in its business (Zhang Wentao, director of the office of the medical and Health Department of the Chinese Academy of Engineering) the guests at the meeting congratulated the 60th birthday of Tianjin Pharmaceutical Research Institute and the smooth opening of the first Biomedical Innovation Summit Forum, witnessed the opening of the new site of Tianjin Pharmaceutical Research Institute and the opening of a new chapter of development of Tianjin Pharmaceutical Research Institute! The opening ceremony of the forum was hosted by Liu Bangmin, CEO of Tianjin Pharmaceutical Research Institute (Liu Bangmin, CEO of Tianjin Pharmaceutical Research Institute) The first Biomedical Innovation Summit Forum aims to promote the development of Chinese medicine and pharmacy, encourage independent innovation, improve the conversion rate of achievements, and achieve the world's advanced level It focuses on the issues, opportunities and challenges of China's biomedical development, and connects universities, scientific research institutes, enterprises and medical institutions with the core of meeting the social demand for high-quality drugs , capital and government, together to enhance the global influence of China's biomedical industry Nearly a thousand experts and scholars gathered together to share in-depth industry insights, stimulate the vitality of pharmaceutical innovation, and focus on the development of China's biomedical industry and seek common development! During the first Biomedical Innovation Summit Forum, three academicians and more than 30 top experts in the professional field shared the theme of the conference, and conducted in-depth exchanges in the four fields of traditional Chinese medicine, chemical medicine, cell products and clinical & Drug Evaluation in the form of sub forums, presenting a feast of biomedical innovation In the keynote report, academician Liu Changxiao took "the challenge of biomedical innovation and development facing 2035" as the title, combined with the policies issued by the state, analyzed the current situation and challenges of the development of the pharmaceutical industry in a panoramic way, predicted the development trend in the next 15 years, put forward the prediction of China's biomedical development from following to leading, and put forward that "intelligent manufacturing, green manufacturing" is the new era of China's biology Innovation is the core of the development of pharmaceutical industry Academician Liu Changxiao's four predictions for the world medicine field in the next 15 years: first, challenges The United States, which is the first to innovate, and India, which is the developing country of medicine, are the challenges of our country The American market share occupied by India will be transferred to our country Its ability to exploit small molecule drugs has advantages and it is expected that the cooperation will have a bright future Second, innovation The development trend of more open medicine globalization is unstoppable Capital technology market promotes merger and acquisition, smart manufacturing and green manufacturing have breakthroughs, and original new drugs will be preferentially applied for review and listing in China; third, imitation The status of generic drugs will not change, the prospect of cooperation between foreign enterprises is promising, the pace of domestic generic drugs to the world is accelerating, and foreign generic drugs enter with their cost and quality advantages, threatening the development of generic drugs in China 4、 Traditional Chinese medicine Evidence based medicine research on the quality and clinical effect of the whole industrial chain is the key The development of classic famous prescriptions will lead to the revolution of research and development of Chinese patent medicine The development prospect of domestic and international demand for treatment of common diseases of Chinese medicine is promising (academician Liu Changxiao, honorary president and lifelong chief scientist of Tianjin Pharmaceutical Research Institute) In the keynote report, academician Yao Xinsheng focused on "the key factors and Strategies of developing new drug products from traditional Chinese medicine and natural medicine", focusing on the demand of modern drug use and the development trend of innovative drugs, combined with the long-term historical development process of traditional Chinese medicine and the experience of constantly expanding to neighboring countries and regions in East Asia such as Japan, focusing on the development and analysis of Chinese medicine in Japan The development direction of traditional Chinese medicine and natural medicine in China is also pointed out (Yao Xinsheng, academician of Chinese Academy of Engineering) Wang Rui shared the topic of "progress in biomedical research - polypeptide drugs as an example" In the more than 110 years since the concept of peptide medicine was put forward, it has won many important breakthroughs in the field of basic research, and has been widely used in the field of anti-tumor, endocrine and other diseases Polypeptide drugs have the characteristics of endogenous, high activity, small dose and low side effects in the aspect of drug formation, and have the advantages of low energy consumption and less pollution in the aspect of production and environmental protection Polypeptide drugs have obvious advantages in various aspects and have great development potential, which is one of the important directions of drug development in the future in China (Academician Wang Rui, Chinese Academy of Engineering) at the symposium celebrating the 50th anniversary of academician Liu Changxiao's work in pharmacokinetic research, academician Chen Kaixian reviewed the experience of working together with academician Liu Changxiao under arduous conditions, saying that academician Liu is also a teacher and a friend! I am grateful for academician Liu's realistic and pragmatic work style in scientific research, and highly praise academician Liu's brilliant achievements in the field of pharmacokinetic research (academician Chen Kaixian, Chinese Academy of Sciences) academician Yang Baofeng expressed warm congratulations on the 60th anniversary of the establishment of Tianjin Pharmaceutical Research Institute, encouraged the researchers to inherit academician Liu Changxiao's innovation professionalism and make greater contributions to the innovation of biomedicine in China (academician Yang Baofeng, Chinese Academy of Engineering) In the theme report, Professor Jiang Jiandong, director of the Institute of medicine of the Chinese Academy of Medical Sciences, Professor Chen Shilin, director of the Institute of traditional Chinese medicine of the Chinese Academy of Medical Sciences, Professor Zhang Weidong of the Second Military Medical University, Professor Guo De'an of the Shanghai Institute of medicine of the Chinese Academy of Sciences, Professor Sun Xiaobo, director of the Institute of medicinal plants of the Chinese Academy of Medical Sciences, Professor Wu Chunfu of the Shenyang University of Pharmaceutical Sciences, and professor of the Chinese Medical Department Professor Cheng Tao, Institute of Hematology, College of Hematology, 7 well-known experts in the industry, respectively with "do a good job in new drug research in China", "quality improvement project of traditional Chinese medicine", "innovative drug discovery based on traditional Chinese medicine", "establishment and application of overall quality standard system of traditional Chinese medicine", "development of new drugs based on clinical big data", "research progress of oxytocin and drug addiction", "stem cell therapy and quality control" Professor Guo De'an, Professor Deng Jiagang, Professor Lin Ruichao and Professor Cheng Maosheng respectively presided over the latest research progress in this field In the four sub forums of traditional Chinese medicine, chemical medicine, cell products and clinical & Drug Evaluation of the summit forum, many authoritative experts and scholars in the field of biomedical launched a variety of in-depth exchanges, sharing the latest research results and exploring the future development direction of pharmaceutical innovation industry Chinese medicine sub Forum Chinese medicine sub forum Professor Li Wenlan